Brain Volume, NfL Level Changes May Predict Disability in Relapsing MS & COVID Vaccines and MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an early MRI measures of brain atrophy and serum NfL levels may accurately predict progression for relapsing forms of MS, a study suggests.

Also, Price reads “More Answers About COVID-19 Vaccines and MS”, a column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/